The University of Alabama at Birmingham Division of Neuropathology has named C. Ryan Miller, M.D., Ph.D., as division director.
Miller was most recently a professor in the Department of Pathology and Laboratory Medicine at the University of North Carolina-Chapel Hill. Miller also served as faculty director of the UNC Translational Pathology Laboratory in conjunction with the Lineberger Comprehensive Cancer Center.
“We are excited to have Dr. Miller back at UAB in the Department of Pathology, where his experience in research on tumors of the brain and work with proteomics will enhance the Neuropathology Division’s portfolio for future growth in this important area,” said Department of Pathology Chair George Netto, M.D.
Miller’s return is a homecoming of sorts. In 1999, prior to medical school, he completed a Ph.D. in the department’s Cellular and Molecular Pathology Graduate Program. He earned his medical degree from the UAB School of Medicine in 2002 and completed a postdoctoral fellowship in the UAB Brain Treatment and Research Program. Miller then moved to Washington University School of Medicine, where he completed a residency in anatomic pathology in 2004 and a fellowship in neuropathology in 2006.
Miller’s research interests focus on novel treatment approaches for malignant gliomas based on molecular alterations for tumorigenesis, using proteomic molecular analyses.
Miller also serves on the neuropathology and neuro-oncology committees of the National Cancer Institute’s Alliance for Clinical Trials in Oncology.
Miller replaces interim division director Vishnu Reddy, M.D., professor in the Division of Laboratory Medicine. His start date is April 15.
Original UAB News article by Adam Pope.
Congratulations to William Grizzle, M.D., Ph.D., Professor, Anatomic Pathology, who was recognized recently by the International Society for Biological and Environmental Repositories (ISBER) with the 2019 Founder's Award. Dr. Grizzle will be presented with this award at the organization's annual meeting in Shanghai, China, May 7-10. ISBER is a global biobanking organization.
"Dr. Grizzle has been a leading individual with great foresight to recognize biobanking as an important and emerging field in science," says David Lewandowski, ISBER President 2018-19. "Since helping to establish ISBER in 1999, he has worked tirelessly to provide the evidence-base to support best practices in biobanking. He is highly regarded by his peers as a reviewer and trainer for start-up biobanks domestically and internationally. We look forward to presenting him with the Prestigious ISBER Founder’s Award in Shanghai at ISBER’s 20th anniversary May 7-10.”
Dr. Grizzle has an AB honors degree (Chemistry and Physics) from Harvard University and Ph.D. (Biophysics) and M.D. degrees from Johns Hopkins University. He is board certified in Anatomic and Clinical Pathology. He served as Head of the Autopsy Section at the UAB and VA hospitals in Birmingham, Alabama, from 1990-2000 and has been head of the program in Translational Research in Neoplasia of the Department of Pathology since 2000. His current research interests include fatty acids in cancer; validation of molecular biomarkers; exosomes and post-transcriptional regulation; molecular imaging, especially multispectral optoacoustic tomography; and biorepository sciences.
Since 1983 Grizzle has served as Director of UAB's Tissue Collection and Banking Facility, and was principle investigator of the Southern Division of the Cooperative Human Tissue Network (CHTN) from 1987-2019, and Director, Biorepository of the Pulmonary Hypertension Breakthrough Initiative (PBHI) from 2006-2019.
Grizzle frequently consults for national and international biorepositories and governmental agencies. He presents workshops on factors accreting and limiting the use of human tissues in research, and histochemical and immunohistochemical staining. He and colleague Katherine Sexton present national and international workshops on the design and operations of biorepositories.
Dr. Grizzle is a founding member of ISBER, and a former council member and President of the organization. In 2015 he received the ISBER Award for Outstanding Achievement in Biobanking. He was a trustee of the Biological Statin Commission (BSC) from 1992-2017, serving as President (2000-2004) and Vice-President (1996-2000). In 2017 Grizzle became a trustee emeritus of the organization.
Grizzle served as a Senior Editor of Clinical Cancer Research from 2010 to 2017, and has served on the editorial boards of numerous other journals. He is currently on the board of Biopreservation and Biobanking; Biotechnic & Histochemistry, and Clinical Cancer Research, and is an associate editor of Cancer Biomarkers. He has published more than 500 peer-reviewed manuscripts and book chapters.
William Grizzle, M.D., Ph.D., Professor, Anatomic Pathology, UAB Department of Pathology
"We are thrilled for Dr. Grizzle at this esteemed recognition from the ISBER on his behalf," says George Netto, M.D., Chair of the Department of Pathology. "His work and expertise in biobanking and biorepositories span several decades, making him one of the field's most respected experts. We thank the ISBER for extending Dr. Grizzle this honor."
The United States and Canadian Academy of Pathology (USCAP) hosted its 108th annual meeting March 16-21, 2019, at the Gaylord National Resort & Convention Center in National Harbor, Maryland, where many of our Department faculty, residents and fellows present recent work. It is the largest world meeting of pathologists.
On Sunday March, 17, Chairman and Professor George Netto, M.D., kicked things off with a talk on "Liquid Biopsy in Precision Oncology: Plasma and Beyond!" at the College of American Pathogists' companion meeting. That evening at 5:30-7:30pm, our team hosted a booth at the Fellowship Fair, featuring information about our fellowship opportunities, giveaways and more. The coursework and poster sessions continued throughout the week until the conference conclusion on Thursday, March 21.
Monday throughout the day our faculty presented posters and talks, including a Genitourinary Platform presentation, "Is MRI/US Fusion-Targeted Biopsy Alone Adequate for Detecting Prostate Cancer in Patients with a Prior Negative Prostate Biopsy?" featuring Maria del Carmen Rodriguez Pena, M.D., Marie-Lise Eich, M.D., and Jennifer Gordetsky, M.D. That evening the Department hosted a reception for all current and former faculty, staff and students, 5-7:30 p.m. in the National Harbor Room 8.
Congratulations to all of the residents who matched today. We are excited to welcome the following individuals to our 2020 residency class:
You can watch UAB School of Medicine's Match Day ceremony from this year and previous years online, here.
Page 107 of 120